Moleculin Biotech MBRX
NASDAQ MBRX
$0.59 +0.00 (+0.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Moleculin Biotech (MBRX) Debt Ratio (2019 - 2022)

Moleculin Biotech (MBRX) posted quarterly Debt Ratio of 0.0 for Q4 2022, up 15.54% year-over-year from 0.0 in Q4 2021, and down 10.99% quarter-over-quarter from 0.0 in Q3 2022.

Moleculin Biotech (MBRX) Debt Ratio (2019 - 2022) Analysis & Trends

Moleculin Biotech's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q4 2022.

  • In Q4 2022, Debt Ratio rose 15.54% year-over-year to 0.0; the TTM figure through Dec 2022 stood at 0.0 (up 15.54% YoY), while the FY2022 annual figure was 0.0, up 15.54% from the prior year.
  • Debt Ratio for Q4 2022 stood at 0.0, down from 0.0 in the prior quarter.
  • The five-year high for Debt Ratio was 0.0 in Q4 2019, with the low at 0.0 in Q1 2021.
  • The 4-year median for Debt Ratio is 0.0 (2022), against an average of 0.0.
  • The sharpest annual moves came in 2021 and 2022: Debt Ratio sank 51.76% in 2021, then soared 65.28% in 2022.
  • Moleculin Biotech's Debt Ratio stood at 0.0 in 2019, then plunged by 31.51% to 0.0 in 2020, then tumbled by 51.76% to 0.0 in 2021, then rose by 15.54% to 0.0 in 2022.
  • Business Quant data shows MBRX's Debt Ratio at 0.0 in Q4 2022, 0.0 in Q3 2022, and 0.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.05
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.03
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.47
10 Moleculin Biotech 3.37 Mn 3.37 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.00
Sep 30, 2020 0.00
Dec 31, 2019 0.00